Happy Thanksgiving! Save 50% on Your MarketBeat All Access Subscription.
  •  days
  •  Hours
  •  Minutes
  •  Seconds
×
S&P 500   4,026.12
DOW   34,347.03
QQQ   286.92
Considerations When Rolling Over a 401(k) into a Roth IRA
See how to make money instead of spending it on Black Friday with this offer (Ad)
Airbnb has a plan to fix cleaning fees
Saudi viewers angry over apparent ban on World Cup streaming
THE BEST BLACK FRIDAY DEAL YET (Ad)
Walmart shooting claims teen, young woman, father, mother
Cuba's informal market finds new space on growing internet
THE BEST BLACK FRIDAY DEAL YET (Ad)
Bird flu prompts slaughter of 1.8M chickens in Nebraska
US-England World Cup game seen by 19.98M on US television
S&P 500   4,026.12
DOW   34,347.03
QQQ   286.92
Considerations When Rolling Over a 401(k) into a Roth IRA
See how to make money instead of spending it on Black Friday with this offer (Ad)
Airbnb has a plan to fix cleaning fees
Saudi viewers angry over apparent ban on World Cup streaming
THE BEST BLACK FRIDAY DEAL YET (Ad)
Walmart shooting claims teen, young woman, father, mother
Cuba's informal market finds new space on growing internet
THE BEST BLACK FRIDAY DEAL YET (Ad)
Bird flu prompts slaughter of 1.8M chickens in Nebraska
US-England World Cup game seen by 19.98M on US television
S&P 500   4,026.12
DOW   34,347.03
QQQ   286.92
Considerations When Rolling Over a 401(k) into a Roth IRA
See how to make money instead of spending it on Black Friday with this offer (Ad)
Airbnb has a plan to fix cleaning fees
Saudi viewers angry over apparent ban on World Cup streaming
THE BEST BLACK FRIDAY DEAL YET (Ad)
Walmart shooting claims teen, young woman, father, mother
Cuba's informal market finds new space on growing internet
THE BEST BLACK FRIDAY DEAL YET (Ad)
Bird flu prompts slaughter of 1.8M chickens in Nebraska
US-England World Cup game seen by 19.98M on US television
S&P 500   4,026.12
DOW   34,347.03
QQQ   286.92
Considerations When Rolling Over a 401(k) into a Roth IRA
See how to make money instead of spending it on Black Friday with this offer (Ad)
Airbnb has a plan to fix cleaning fees
Saudi viewers angry over apparent ban on World Cup streaming
THE BEST BLACK FRIDAY DEAL YET (Ad)
Walmart shooting claims teen, young woman, father, mother
Cuba's informal market finds new space on growing internet
THE BEST BLACK FRIDAY DEAL YET (Ad)
Bird flu prompts slaughter of 1.8M chickens in Nebraska
US-England World Cup game seen by 19.98M on US television
NASDAQ:NRC

National Research - NRC Stock Forecast, Price & News

$37.77
+0.49 (+1.31%)
(As of 11/25/2022 08:58 PM ET)
Add
Compare
Today's Range
$37.37
$37.77
50-Day Range
$35.23
$41.21
52-Week Range
$30.93
$44.05
Volume
11,400 shs
Average Volume
42,764 shs
Market Capitalization
$932.58 million
P/E Ratio
27.37
Dividend Yield
2.54%
Price Target
N/A

National Research MarketRank™ Forecast

Analyst Rating
N/A
Upside/​Downside
N/A
Short Interest
Healthy
1.63% of Float Sold Short
Dividend Strength
Weak
Based on Four Factors
Sustainability
N/A
News Sentiment
0.11mentions of National Research in the last 14 days
Based on 3 Articles This Week
Insider Trading
Selling Shares
$9.82 M Sold Last Quarter
Proj. Earnings Growth
N/A

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.07 out of 5 stars

Business Services Sector

238th out of 329 stocks

Commercial Physical Research Industry

16th out of 16 stocks

NRC stock logo

About National Research (NASDAQ:NRC) Stock

National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience in the United States and Canada. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, health risk assessments, employee engagement, reputation management, and brand loyalty. The company also offers market insights solutions that allow the tracking of awareness, perception, and consistency of healthcare brands; assessment of competitive differentiators; and enhanced segmentation tools to evaluate needs, wants, and behaviors of communities through real-time competitive assessments and enhanced segmentation tools. In addition, it provides experience solutions, such as patient and resident experience, workforce engagement, health risk assessments, transitions, and improvement tools. Further, the company offers health risk assessment solutions that enable clients to segment populations and manage care for those who are most at risk, engage individuals, enhance preventative care, and manage wellness programs; and transitions solutions, which enable organizations to identify and manage high-risk patients to reduce readmissions, enhance patient satisfaction and support safe care transitions. Additionally, it provides transparency solutions that allow healthcare organizations to share picture of their organization and ensure content informs in consumer decision-making; and governance solutions for not-for-profit hospital and health system boards of directors, executives, and physician leadership. The company serves integrated health systems, post-acute providers, and payer organizations. National Research Corporation was founded in 1981 and is headquartered in Lincoln, Nebraska.

Receive NRC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for National Research and its competitors with MarketBeat's FREE daily newsletter.

NRC Stock News Headlines

Massive Insider Trade At National Research
National Research Corp.
National Research Corp
See More Headlines
Receive NRC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for National Research and its competitors with MarketBeat's FREE daily newsletter.

NRC Company Calendar

Last Earnings
2/11/2020
Ex-Dividend for 10/14 Dividend
9/29/2022
Dividend Payable
10/14/2022
Today
11/27/2022
Ex-Dividend for 1/13 Dividend
12/29/2022
Fiscal Year End
12/31/2022
Dividend Payable
1/13/2023
Next Earnings (Estimated)
2/14/2023

Industry, Sector and Symbol

Industry
Commercial physical research
Sub-Industry
N/A
Current Symbol
NASDAQ:NRC
Employees
511
Year Founded
N/A

Profitability

Net Income
$37.47 million
Pretax Margin
30.21%

Debt

Sales & Book Value

Annual Sales
$147.95 million
Cash Flow
$1.73 per share
Book Value
$3.36 per share

Miscellaneous

Free Float
24,197,000
Market Cap
$932.58 million
Optionable
Not Optionable
Beta
0.50

Key Executives

  • Mr. Michael D. Hays (Age 67)
    Founder, CEO, Pres & Director
    Comp: $167.5k
  • Mr. Kevin R. Karas CPA (Age 64)
    CPA, Sr. VP of Fin., CFO, Treasurer & Sec.
    Comp: $371.6k
  • Ms. Jona S. Raasch (Age 63)
    Chief Operating Officer
    Comp: $389.35k
  • Ms. Helen L. Hrdy (Age 57)
    Chief Growth Officer
    Comp: $371.74k
  • Mr. Jon Boumstein
    Chief Delivery Officer
  • Dr. Gregory Makoul M.S.
    Ph.D., Chief Transformation Officer
  • Linda Stacy
    VP of Fin.
  • Megan Charko
    Sr. Mang. of Content Marketing













NRC Stock - Frequently Asked Questions

How have NRC shares performed in 2022?

National Research's stock was trading at $41.52 at the start of the year. Since then, NRC shares have decreased by 9.0% and is now trading at $37.77.
View the best growth stocks for 2022 here
.

When is National Research's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, February 14th 2023.
View our NRC earnings forecast
.

How were National Research's earnings last quarter?

National Research Co. (NASDAQ:NRC) announced its earnings results on Tuesday, February, 11th. The company reported $0.34 earnings per share for the quarter. The firm had revenue of $32.62 million for the quarter. National Research had a net margin of 22.93% and a trailing twelve-month return on equity of 45.90%.

How often does National Research pay dividends? What is the dividend yield for National Research?

National Research declared a quarterly dividend on Friday, November 11th. Investors of record on Friday, December 30th will be paid a dividend of $0.12 per share on Friday, January 13th. This represents a $0.48 dividend on an annualized basis and a yield of 1.27%. The ex-dividend date of this dividend is Thursday, December 29th.
Read our dividend analysis for NRC
.

Is National Research a good dividend stock?

National Research (NASDAQ:NRC) pays an annual dividend of $0.96 per share and currently has a dividend yield of 2.54%. The dividend payout ratio is 69.57%. This payout ratio is at a healthy, sustainable level, below 75%.
Read our dividend analysis for NRC.

What is Michael D. Hays' approval rating as National Research's CEO?

85 employees have rated National Research Chief Executive Officer Michael D. Hays on Glassdoor.com. Michael D. Hays has an approval rating of 87% among the company's employees.

What other stocks do shareholders of National Research own?

Based on aggregate information from My MarketBeat watchlists, some companies that other National Research investors own include Altria Group (MO), Enterprise Products Partners (EPD), AbbVie (ABBV), Dominion Energy (D), Gilead Sciences (GILD), Pfizer (PFE), Toronto-Dominion Bank (TD), Verizon Communications (VZ), Wells Fargo & Company (WFC) and TD Ameritrade (AMTD).

What is National Research's stock symbol?

National Research trades on the NASDAQ under the ticker symbol "NRC."

Who are National Research's major shareholders?

National Research's stock is owned by many different institutional and retail investors. Top institutional shareholders include Kayne Anderson Rudnick Investment Management LLC (13.09%), BlackRock Inc. (3.78%), Vanguard Group Inc. (3.45%), Conestoga Capital Advisors LLC (2.90%), Dimensional Fund Advisors LP (2.49%) and QV Investors Inc. (1.84%). Insiders that own company stock include Amandla Mk Trust, Joann M Martin, John N Nunnelly, Kevin R Karas and Steven D Jackson.
View institutional ownership trends
.

How do I buy shares of National Research?

Shares of NRC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is National Research's stock price today?

One share of NRC stock can currently be purchased for approximately $37.77.

How much money does National Research make?

National Research (NASDAQ:NRC) has a market capitalization of $932.54 million and generates $147.95 million in revenue each year. The company earns $37.47 million in net income (profit) each year or $1.38 on an earnings per share basis.

How many employees does National Research have?

The company employs 511 workers across the globe.

How can I contact National Research?

National Research's mailing address is 1245 Q STREET, LINCOLN NE, 68508. The official website for the company is www.nrchealth.com. The company can be reached via phone at (402) 475-2525 or via fax at 402-475-9061.

This page (NASDAQ:NRC) was last updated on 11/28/2022 by MarketBeat.com Staff